PERSPECTA

News from every angle

Back to headlines

Pelthos Therapeutics Misses GAAP EPS, Beats Revenue Estimates in Q4

Pelthos Therapeutics reported a GAAP EPS of -$6.87, missing estimates, but its revenue of $9.39 million surpassed expectations for the quarter.

19 Mar, 10:36 — 19 Mar, 10:36
PostShare

Sources

Showing 1 of 1 sources